Literature DB >> 839593

Carcinoma of the prostate: a critical look at staging.

A W Bruce, F O'Cleireachain, A Morales, S A Awad.   

Abstract

To stage accurately the extent of the disease comprehensive investigations were done on 75 patients with histologically documented carcinoma of the prostate. Estimation of bone marrow acid phosphatase appears to be the most sensitive test to detect blood-borne metastases. Serum acid phosphatase appears to be of little value in the detection of early blood spread and may have a role only in monitoring the effect of treatment on advanced disease. Bone scanning with technetium compounds has the disadvantage of non-specificity but has far greater sensitivity than a skeletal survey. Bone marrow cytology was not rewarding in the detection of early metastatic disease. Pedal lymphangiography is a highly inaccurate method to detect lymphatic spread of carcinoma of the prostate and pelvic lymphadenectomy, when indicated, remains the only truly adequate method to assess lymph node involvement. There was a 37 per cent incidence of metastatic lymph node pathology in 30 patients undergoing this procedure before either radical prostatectomy or deep x-ray therapy. A close correlation was found between stage and grade of disease and incidence of nodal pathology. There was some correlation between degree of nodal involvement and evidence of blood spread as detected by elevated bone marrow acid phosphatase levels. The significance of this finding remains unclear.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 839593     DOI: 10.1016/s0022-5347(17)58446-3

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  Early (stage A) prostatic cancer. IV. Methodological criteria for histopathological diagnosis.

Authors:  S Battaglia; G Barbolini; A R Botticelli
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979-06-29

2.  Assessment of the regional lymph node status in radiation monotherapy of prostatic cancer.

Authors:  L U Kelly; P Moravek; J Schubert; J Wehnert
Journal:  Int Urol Nephrol       Date:  1986       Impact factor: 2.370

Review 3.  Radiologic imaging modalities, including magnetic resonance, for evaluating lymph nodes.

Authors:  G C Dooms; H Hricak
Journal:  West J Med       Date:  1986-01

4.  Early (stage A) prostatic cancer. VI. A critical look at the follow-up.

Authors:  S Battaglia; G Barbolini; A R Botticelli; G Berri; E Nigrisoli
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

Review 5.  Prostatic carcinoma: aspects of pathology, prognosis, and therapy.

Authors:  H Kastendieck
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

6.  Adenocarcinoma of the prostate in perspective.

Authors:  A W Bruce; D E Mahan
Journal:  Can Med Assoc J       Date:  1978-11-04       Impact factor: 8.262

7.  Equivocal test results and prognostic staging uncertainties in the evaluation of patients with cancer of the prostate.

Authors:  J D Clemens; B Stanton; N B Holabird; S Cartwright
Journal:  Yale J Biol Med       Date:  1986 Jan-Feb
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.